Point72 Asset Management
OXFD

Point72 Asset Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Point72 Asset Management’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-200,000
Closed -$2.49M – 1259
2018
Q1 		$2.49M Sell
200,000
-306,400
-61% -$3.73M 0.01% 705
2017
Q4 		$7.07M Buy
+506,400
New +$7.42M 0.03% 522

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Point72 Asset Management's OXFD Position: Q2 2018 in Review

Point72 Asset Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2018, closing a stake of 200,000 shares — an estimated $2.49M sold.

Point72 Asset Management first reported a position in OXFD in Q4 2017 and held it in 2 quarters. The position peaked at $7.07M in Q4 2017. 77 funds tracked by Wall St. Rank hold OXFD as of Q2 2018.

  • Point72 Asset Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2018 after selling out during the quarter.
  • Point72 Asset Management sold 200,000 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2018, an estimated $2.49M.
  • Point72 Asset Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2017 and held it in 2 quarters.
  • Point72 Asset Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $7.07M in Q4 2017.
  • 77 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2018.

Based on Point72 Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.